# FASENRA SCEI for Long-term Use

> **NCT03588546** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 653 (actual)

## Conditions studied

- Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03588546
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-31
- **Primary completion:** 2024-09-10
- **Final completion:** 2024-09-10
- **Target enrollment:** 653 (ACTUAL)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03588546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03588546, "FASENRA SCEI for Long-term Use". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03588546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*